‹ ›
MYP_128071
Basic Information
Buserelin
Anticancer
Hormonal / Endocrine ▸ Hormone peptide
not Standard
9 amino acids
-
contains X representing unresolved or non-standard residue
Sequence
XHWSYXLRP
Physicochemical Analysis
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available

Not available: incomplete physicochemical profile.

Molecular Weight
Not available
Isoelectric Point (pI)
Not available
Net Charge (pH 7.0)
Not available
GRAVY Index
Not available
Boman Index
Not available
Instability Index
Not available
The radar chart requires all six dimensions. Available values are listed above; missing values are not plotted as zero.
Residue Composition
Amino Acid Composition
Chemical Descriptors
Structural Visualization
3D PDB MODEL
Readable PDBLast file check: 2026-11-18T21:14:26.456095+00:00. File readability does not guarantee 3D display.
Match index: Listed
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0245075 REVIEWED: NO
Provenance & Taxonomy
synthetic construct [Synthetic]
Enzyme
32630
Structure & Mods
linear peptide/protein therapeutic [Linear]
noncanonical stereochemical or chemical modification [Modified]
Ambiguous/noncanonical residue symbol X present in deposited sequence
Bio-Activity Profile
Anticancer Hormone replacement
CHO
50-80 minutes by IV dose, 80 mins. By SC dose, 1-2 hrs by Intranasal dose
RECORD: Rec_0257843 REVIEWED: YES
Provenance & Taxonomy
Homo sapiens [Animal]; synthetic construct [Synthetic]
GnRH
9606;32630
Structure & Mods
linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
Hydrazide
Non-standard residues/X at 1, 6
Bio-Activity Profile
GnRH agonist Endocrine Anticancer
Human GnRH receptor
Clinical/Human: 4-5 h
RECORD: Rec_0311550 REVIEWED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
GnRH analog
32630
Structure & Mods
linear synthetic GnRH analog [Linear]
mixed L/D amino-acid peptide [Mixed]
Pyroglutamate
Ethylamide
D-Ser(tBu) at position 6
Bio-Activity Profile
Endocrine GnRH agonist Hormone therapy
50-80 minby IV dose, 80 min. By SC dose, 1-2 h by Intranasal dose
RECORD: Rec_0329711 REVIEWED: YES
Provenance & Taxonomy
Homo sapiens [Animal]; synthetic construct [Synthetic]
GnRH
9606;32630
Structure & Mods
linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
Pyroglutamate
N-ethylamide
Non-standard residues/X at 1, 6
Bio-Activity Profile
GnRH agonist Endocrine
Human GnRH receptor
Clinical/Human: 3.92 ± 1.01 hr